Skip to contentR
Repligen Corp
R
RGENRepligen Corp Q3 2015 · 10-Q
Revenue$19.81M$19.81M+29.7% vs Q3 2014 Net Income$2.54M$2.54M+73.1% vs Q3 2014 EPS Diluted$0.08$0.08+100.0% vs Q3 2014 Operating Income$3,688,000+66.4% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Repligen Corp · CIK 730272 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$6,270,000+36.7% Margins · derivedOperating margin18.6%+4.1 pt vs Q3 2014
Net margin12.8%+3.2 pt vs Q3 2014
ended Sep 30, 2015 · filed Nov 5, 2015 · 36 d after period end